Gilead Teases Big Cancer Drug Readouts In Second Half

 
• By Alaric DeArment
  
Cancer cells on scientific background.3d illustration
Gilead announced its second quarter earnings, highlighting developments in virology as well as oncology • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business